Buy or sell Athelas stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Athelas Stock
Athelas - rapid diagnostics through Deep Learning.
About Athelas Stock
Athelas utilizes deep learning and computer vision to rapidly analyze tissue samples for diagnostics. The product is used for immune monitoring, blood counts, and parasite diagnostics.
Funding History
February 2016 | $0 |
---|---|
August 2016 | $120K |
January 2017 | $3.5M |
Management
Founder
Tanay Tandon
Product Manager
Steve Moffatt
Press
New At-Home CBC Device Enables Complete Blood Testing for Cancer Treatments and Biological/Viral Monitoring - DARKDaily.com
Laboratory News - May, 11 2018
Athelas Device Provides Accurate CBC Testing – From Home
Medgadget (blog) - Sep, 6 2017
Test your blood from the comfort of your home with Athelas
Digital Trends - Aug, 29 2017
Athelas launches a new type of blood testing device for the home
TechCrunch - Aug, 28 2017
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase